Long-term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease.

Hisashi ShigaKunio TarasawaRintaro MoroiMotoki MakuuchiTakahiro TakahashiYusuke ShimoyamaMasatake KurohaYoichi KakutaKiyohide FushimiKenji FujimoriYoshitaka KinouchiAtsushi Masamune

Published in: Journal of gastroenterology and hepatology (2022)

Anti-TNF agents and UST appear to have comparable effectiveness for CD patients without prior use of biologics.

Keyphrases

end stage renal disease
randomized controlled trial
systematic review
ejection fraction
chronic kidney disease
rheumatoid arthritis
prognostic factors
peritoneal dialysis
patient reported outcomes
nk cells